Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report
Revista Cientifica Internacional de Ciencias de la Salud · 31.03.2026 · 3 (1) · 67-72
DOI: 10.57188/ricsa.2026.010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Revista Cientifica Internacional de Ciencias de la Salud, online erschienen am 31.03.2026. Verfasst von Luz M. Moyano Vidal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Fixed drug eruption (FDE) is a delayed hypersensitivity reaction characterized by erythematous- violaceous plaques recurring at identical anatomical sites upon re-exposure to the causative drug, with persistent residual hyperpigmentation. Etoricoxib, a widely used COX-2 inhibitor, is an increasingly recognized trigger. Case Report: A 49-year-old woman developed hyperpigmented plaques on the arms and oral mucosa eight hours after a single dose of etoricoxib 120 mg for acute low back pain. A clinically identical episode had occurred two years earlier at the same sites, initially misdiagnosed as herpetic infection. Diagnosis was established by temporal chronology, exact anatomical recurrence, and a Naranjo score of 10 (definite causal relationship). Management comprised drug discontinuation, oral antihistamine, and topical corticosteroid, with favorable outpatient evolution.
Conclusion
This case illustrates etoricoxib-induced FDE with cutaneous and mucosal involvement and exact site recurrence. Early recognition, definitive discontinuation, and pharmacovigilance reporting are clinical imperatives to prevent recurrence and ensure safe alternatives.
Zitieren
APA
Vidal, L. M. M., Bolivar-Herrada, L. M., & Guevara, M. P. D. (2026). Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report. Revista Cientifica Internacional de Ciencias de la Salud, 3(1), 67-72. https://doi.org/10.57188/ricsa.2026.010
Vancouver
Vidal LMM, Bolivar-Herrada LM, Guevara MPD. Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report. Revista Cientifica Internacional de Ciencias de la Salud. 2026;3(1):67-72. doi:10.57188/ricsa.2026.010
BibTeX
@article{Vidal2026,
author = {Vidal, Luz M. Moyano and Bolivar-Herrada, Lucia M. and Guevara, Martha Patricia Diaz},
title = {Etoricoxib-Induced Fixed Drug Eruption with Cutaneous and Mucosal Involvement: A Case Report},
journal = {Revista Cientifica Internacional de Ciencias de la Salud},
year = {2026},
volume = {3},
number = {1},
pages = {67--72},
doi = {10.57188/ricsa.2026.010}
}
EUVIMED